The technology will be integrated into the Accenture Touchless Testing Platform to strengthen its analytics and cognitive capabilities.
Accenture has acquired an AI technology from Real Time Analytics Platform, Inc. The newly acquired technology will be integrated into Accenture’s Touchless testing platform to strengthen its analytics and cognitive capabilities.
Real Time Analytics platform utilizes AI as machine learning, natural language processing and neural networks to analyze each stage of software testing so that users can use the insights gleaned from the collected data to optimize test case execution, reduce defects and improve human decision making. These tools will complement Accenture’s Touchless Testing platform to help speed the adoption of extreme automation and AI-enabled services.
See also: Time to put AI in proper perspective
“Continuous testing is increasingly important as companies look to software as a means of competitive advantage,” said Kishore Durg, senior managing director, Growth & Strategy and global testing lead for Accenture Technology. “With advances in AI and analytics, we can find inefficiencies and eliminate them, improving business productivity by up to 50 percent. The integration of Real Time Analytics Platform will further enhance the AI-driven capabilities of the Accenture Touchless Testing Platform to help our clients increase productivity and agility.”
Sam Bhat, CEO, Real Time Analytics Platform, Inc. added, “As more organizations embrace digital transformation, the demand for testing and quality assurance will only increase as it’s a critical component for ensuring new applications meet the demands of the business. We’re excited about the value our platform will bring to their already robust offerings in this space.”
Earlier this year Accenture launched new services for AI systems testing. Powered by what they call a “Teach and Test” methodology, the services are designed to help companies evaluate the safety and reliability of their AI systems. The company holds over 250 patents and pending patents related to software testing.
Terms of the deal were not disclosed.